Active, Not Recruiting
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)
NCT02736656
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
- Locations
-
- Woodland International Research Group Little Rock, Arkansas, United States
- Alliance for Wellness dba Alliance for Research Long Beach, California, United States
- MCB Clinical Research Centers, LLC Colorado Springs, Colorado, United States
- Meridien Research at Florida Clinical Research Center Bradenton, Florida, United States